DrugRisk Update: Judge Greenlights First NuvaRing Lawsuit For Trial

July 24, 2013

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

New York, NY (PRWEB) July 24, 2013

The birth control safety advocates at DrugRisk.com are announcing updated news for women using the contraceptive NuvaRing. A federal judge recently denied attempts by the manufacturer to dismiss a lawsuit alleging NuvaRing caused blood clots, allowing trials to proceed in October*.

Health experts have linked contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.

So far, 1,296 women or families have filed a NuvaRing lawsuit alleging blood clots, an increase of 11% in recent months***. Cases have been consolidated in a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

Now, the resource center has learned that U.S. District Judge Rodney Sippel, who is overseeing the litigation, recently denied a motion filed by Merck subsidiary Organon USA to dismiss the case of Marianne Prather alleging DVT and pulmonary embolism from the device*. The first trial for these lawsuits has been scheduled to start in October***.

DrugRisk was created to improve the safety and awareness of patients using popular prescription drugs by providing the latest safety alerts, recalls, studies and legal news. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.

Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Center or speak with a lawyer about their legal rights as soon as possible. DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*U.S. District Judge Rodney Sippel, 7/12/13; Case: 4:08-md-01964-RWS Doc. #: 1598

**New England Journal of Medicine, 6/14/12; nejm.org/doi/full/10.1056/NEJMoa1111840

***JPML 7/10/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-July-10-2013.pdf

****U.S. District Judge Rodney Sippel, 3/8/13; cdn.aboutlawsuits.com/wp-content/uploads/2013-03-08-NuvaRing-Order.pdf

For the original version on PRWeb visit: http://www.prweb.com/releases/nuvaring-litigation-2013/lawsuit-update/prweb10956575.htm

Source: prweb

comments powered by Disqus